Investigation of the effects of carbon-based nanomaterials on A53T alpha-synuclein aggregation using a whole-cell recombinant biosensor

References

• RecchiaADebettoPNegroAGuidolinDSkaperSDGiustiPα-Synuclein and Parkinson’s diseaseFASEB J200418661762615054084
   PubMed Web of Science ®Google Scholar
• HoehnMMYahrMDParkinsonism: onset, progression, and mortalityNeurology19985023183339484345
   PubMed Web of Science ®Google Scholar
• LothariusJBrundinPPathogenesis of Parkinson’s disease: dopamine, vesicles and α-synucleinNat Rev Neurosci200231293294212461550
   PubMed Web of Science ®Google Scholar
• Gomez-TortosaENewellKIrizarryMAlbertMGrowdonJHymanBClinical and quantitative pathologic correlates of dementia with Lewy bodiesNeurology19995361284129110522886
   PubMed Web of Science ®Google Scholar
• SingletonAFarrerMJohnsonJα-Synuclein locus triplication causes Parkinson’s diseaseScience2003302564684114593171
   PubMed Web of Science ®Google Scholar
• LiJUverskyVNFinkALEffect of familial Parkinson’s disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human α-synucleinBiochemistry20014038116041161311560511
   PubMed Web of Science ®Google Scholar
• ConwayKALeeS-JRochetJ-CDingTTWilliamsonRELansburyPTAcceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson’s disease: implications for pathogenesis and therapyProc Natl Acad Sci U S A200097257157610639120
   PubMed Web of Science ®Google Scholar
• PandeyNSchmidtREGalvinJEThe alpha-synuclein mutation E46K promotes aggregation in cultured cellsExp Neurol2006197251552016325180
   PubMed Web of Science ®Google Scholar
• LashuelHAHartleyDPetreBMWalzTLansburyPTNeurode-generative disease: amyloid pores from pathogenic mutationsNature20024186895291
   PubMed Web of Science ®Google Scholar
• EmadiSBarkhordarianHWangMSSchulzPSierksMRIsolation of a human single chain antibody fragment against oligomeric α-synuclein that inhibits aggregation and prevents α-synuclein-induced toxicityJ Mol Biol200736841132114417391701
   PubMedGoogle Scholar
• El-AgnafOMSalemSAPaleologouKEDetection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson’s diseaseFASEB J200620341942516507759
   PubMed Web of Science ®Google Scholar
• EmadiSKasturiranganSWangMSSchulzPSierksMRDetecting morphologically distinct oligomeric forms of α-synucleinJ Biol Chem200928417110481105819141614
   PubMed Web of Science ®Google Scholar
• KanazawaTAkiyamaFKakizakiSTakashimaYSetaYDelivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micellesBiomaterials201334369220922623992922
   PubMed Web of Science ®Google Scholar
• PatelPJAcharyaNSAcharyaSRDevelopment and characterization of glutathione-conjugated albumin nanoparticles for improved brain delivery of hydrophilic fluorescent markerDrug Deliv2013203–414315523734981
   PubMed Web of Science ®Google Scholar
• ChopraDGulatiMSalujaVPathakPBansalPBrain permeable nanoparticlesRecent Pat CNS Drug Discov20083321622518991811
   PubMedGoogle Scholar
• WangX-YLeiRHuangH-DThe permeability and transport mechanism of graphene quantum dots (GQDs) across the biological barrierNanoscale2015752034204125553649
   PubMed Web of Science ®Google Scholar
• KongSDLeeJRamachandranSMagnetic targeting of nano-particles across the intact blood–brain barrierJ Control Release20121641495723063548
   PubMed Web of Science ®Google Scholar
• TriulziRCDaiQZouJPhotothermal ablation of amyloid aggregates by gold nanoparticlesColloids Surf B Biointerfaces200863220020818262396
   PubMed Web of Science ®Google Scholar
• MarcatoPDDuránNNew aspects of nanopharmaceutical delivery systemsJ Nanosci Nanotechnol2008852216222918572633
   PubMed Web of Science ®Google Scholar
• De JongWHBormPJDrug delivery and nanoparticles: applications and hazardsIntJ Nanomed200832133
   PubMed Web of Science ®Google Scholar
• NieSXingYKimGJSimonsJWNanotechnology applications in cancerAnnu Rev Biomed Eng2007925728817439359
   PubMed Web of Science ®Google Scholar
• O’BrienEPStraubJEBrooksBRThirumalaiDInfluence of nano-particle size and shape on oligomer formation of an amyloidogenic peptideJ Phys Chem Lett20112101171117721691423
   PubMedGoogle Scholar
• MirsadeghiSDinarvandRGhahremaniMHProtein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation processNanoscale20157115004501325695421
   PubMed Web of Science ®Google Scholar
• HuangRCarneyRPStellacciFLauBLProtein–nanoparticle interactions: the effects of surface compositional and structural heterogeneity are scale dependentNanoscale20135156928693523787874
   PubMedGoogle Scholar
• Cabaleiro-LagoCSzczepankiewiczOLinseSThe effect of nano-particles on amyloid aggregation depends on the protein stability and intrinsic aggregation rateLangmuir20122831852185722168533
   PubMedGoogle Scholar
• MarshallKEMorrisKLCharltonDHydrophobic, aromatic, and electrostatic interactions play a central role in amyloid fibril formation and stabilityBiochemistry201150122061207121288003
   PubMed Web of Science ®Google Scholar
• RobertiMJMorganMMenéndezGPietrasantaLIJovinTMJares-ErijmanEAQuantum dots as ultrasensitive nanoactuators and sensors of amyloid aggregation in live cellsJ Am Chem Soc2009131238102810719462994
   PubMedGoogle Scholar
• YangJALinWWoodsWSGeorgeJMMurphyCJα-Synuclein’s adsorption, conformation, and orientation on cationic gold nanoparticle surfaces seeds global conformation changeJ Phys Chem B2014118133559357124635210
   PubMedGoogle Scholar
• YangJAJohnsonBJWuSWoodsWSGeorgeJMMurphyCJStudy of wild-type α-synuclein binding and orientation on gold nanoparticlesLangmuir201329144603461523477540
   PubMedGoogle Scholar
• ÁlvarezYDFauerbachJAPellegrottiJVJovinTMJares-ErijmanEAStefaniFDInfluence of gold nanoparticles on the kinetics of α-synuclein aggregationNano Lett201313126156616324219503
   PubMedGoogle Scholar
• JoshiNBasakSKunduSDeGMukhopadhyayAChattopadhyayKAttenuation of the early events of α-synuclein aggregation: a fluorescence correlation spectroscopy and laser scanning microscopy study in the presence of surface-coated Fe3O4 nanoparticlesLangmuir20153141469147825561279
   PubMedGoogle Scholar
• ZamanMAhmadEQadeerARabbaniGKhanRHNanoparticles in relation to peptide and protein aggregationInt J Nanomedicine2014989991224611007
   PubMed Web of Science ®Google Scholar
• HashimotoTAdamsKWFanZMcLeanPJHymanBTCharacterization of oligomer formation of amyloid-β peptide using a split-luciferase complementation assayJ Biol Chem201128631270812709121652708
   PubMedGoogle Scholar
• AzadTTashakorAHosseinkhaniSSplit-luciferase complementary assay: applications, recent developments, and future perspectivesAnal Bioanal Chem2014406235541556025002334
   PubMed Web of Science ®Google Scholar
• Torkzadeh-MahaniMAtaeiFNikkhahMHosseinkhaniSDesign and development of a whole-cell luminescent biosensor for detection of early-stage of apoptosisBiosens Bioelectron201238136232822770903
   PubMedGoogle Scholar
• OzawaTDesigning split reporter proteins for analytical toolsAnal Chim Acta20065561586817723331
   PubMedGoogle Scholar
• TakeuchiMNagaokaYYamadaTTakakuraHOzawaTRatiometric bioluminescence indicators for monitoring cyclic adenosine 3′,5′-monophosphate in live cells based on luciferase-fragment complementationAnal Chem201082229306931320979393
   PubMedGoogle Scholar
• MisawaNKafiAHattoriMMiuraKMasudaKOzawaTRapid and high-sensitivity cell-based assays of protein–protein interactions using split click beetle luciferase complementation: an approach to the study of G-protein-coupled receptorsAnal Chem20108262552256020180537
   PubMedGoogle Scholar
• SambrookJFritschEFManiatisTMolecular CloningNew YorkCold Spring Harbor Laboratory Press1989
   Google Scholar
• ChoosakoonkriangSLoboBAKoeGSKoeJGMiddaughCRBiophysical characterization of PEI/DNA complexesJ Pharm Sci20039281710172212884257
   PubMed Web of Science ®Google Scholar
• NazariMHosseinkhaniSDesign of disulfide bridge as an alternative mechanism for color shift in firefly luciferase and development of secreted luciferasePhotochem Photobiol Sci20111071203121521494742
   PubMedGoogle Scholar
• CaldinelliLAlbaniDPollegioniLOne single method to produce native and Tat-fused recombinant human α-synuclein in Escherichia coliBMC Biotechnol2013131123281894
   PubMedGoogle Scholar
• SalehniaFFaridbodFDezfuliASGanjaliMRNorouziPCerium (III) ion sensing based on graphene quantum dots fluorescent turn-offJ Fluoresc201727133133827838801
   PubMedGoogle Scholar
• UnsoyGYalcinSKhodadustRGunduzGGunduzUSynthesis optimization and characterization of chitosan-coated iron oxide nano-particles produced for biomedical applicationsJ Nanopart Res2012141111322448125
   PubMed Web of Science ®Google Scholar
• OuteiroTFPutchaPTetzlaffJESpoelgenRKokerMCarvalhoFFormation of toxic oligomeric α-synuclein species in living cellsPLoS One200834e186718382657
   PubMed Web of Science ®Google Scholar
• WangMSBoddapatiSEmadiSSierksMRCurcumin reduces α-synuclein induced cytotoxicity in Parkinson’s disease cell modelBMC Neurosci20101111
   Google Scholar
• AhmadBLapidusLJCurcumin prevents aggregation in α-synuclein by increasing reconfiguration rateJ Biol Chem2012287129193919922267729
   PubMed Web of Science ®Google Scholar
• Erfani-MoghadamVNomaniAZamaniMYazdaniYNajafiFSadeghizadehMA novel diblock of copolymer of (monomethoxy poly [ethylene glycol]-oleate) with a small hydrophobic fraction to make stable micelles/polymersomes for curcumin delivery to cancer cellsInt J Nanomedicine2014915541555425489242
   PubMedGoogle Scholar
• RejmanJOberleVZuhornISHoekstraDSize-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosisBiochem J2004377115916914505488
   PubMedGoogle Scholar
• ConnerSDSchmidSLRegulated portals of entry into the cellNature20034226927374412621426
   PubMed Web of Science ®Google Scholar
• GalvagnionCBuellAKMeislGLipid vesicles trigger α-synuclein aggregation by stimulating primary nucleationNat Chem Biol201511322923425643172
   PubMed Web of Science ®Google Scholar
• AkhavanOGhaderiEEscherichia coli bacteria reduce graphene oxide to bactericidal graphene in a self-limiting mannerCarbon201250518531860
   Web of Science ®Google Scholar
• ZhuSZhangJQiaoCStrongly green-photoluminescent graphene quantum dots for bioimaging applicationsChem Commun (Camb)201147246858686021584323
   PubMed Web of Science ®Google Scholar
• AelvoetSAIbrahimiAMacchiFNoninvasive bioluminescence imaging of α-synuclein oligomerization in mouse brain using split firefly luciferase reportersJ Neurosci20143449165181653225471588
   PubMed Web of Science ®Google Scholar
• LinseSCabaleiro-LagoCXueWFNucleation of protein fibrillation by nanoparticlesProc Natl Acad Sci U S A2007104218691869617485668
   PubMed Web of Science ®Google Scholar
• ColvinVLKulinowskiKMNanoparticles as catalysts for protein fibrillationProc Natl Acad Sci U S A2007104218679868017502593
   PubMed Web of Science ®Google Scholar
• Cabaleiro-LagoCQuinlan-PluckFLynchIInhibition of amyloid β protein fibrillation by polymeric nanoparticlesJ Am Chem Soc200813046154371544318954050
   PubMed Web of Science ®Google Scholar
• LiuYXuL-PDaiWDongHWenYZhangXGraphene quantum dots for the inhibition of β amyloid aggregationNanoscale2015745190601906526515666
   PubMed Web of Science ®Google Scholar
• KimJELeeMFullerene inhibits β-amyloid peptide aggregationBiochem Biophys Res Commun2003303257657912659858
   PubMedGoogle Scholar